Risperidone related Raynaud's phenomenon: An adolescent case
Clinical Psychopharmacology and Neuroscience, cilt.16, sa.1, ss.118-121, 2018 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 16 Sayı: 1
- Basım Tarihi: 2018
- Doi Numarası: 10.9758/cpn.2018.16.1.118
- Dergi Adı: Clinical Psychopharmacology and Neuroscience
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.118-121
- Anahtar Kelimeler: Adolescent, Case report, Child, Raynaud's phenomenon, Risperidone
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Raynaud's phenomenon is a recurrent vasospastic condition with reducing in peripheral blood flow due to cold, or emotional stress. White, blue and red discolorations occur during the attacks. Serotonin reuptake inhibitors, psychostimulants, and aripiprazole are reported to be related with Raynaud's phenomenon. Risperidone is an atypical antipsychotic drug with dopaminergic and serotonergic effects. In children and adolescents, risperidone is used for bipolar disorder, tic disorders, conduct disorder, schizophrenia, symptoms of irritability and self-mutilation. Here we report a case of Raynaud's phenomenon associated with risperidone in a 12-year-old boy. Raynaud's phenomenon occurred two weeks after starting risperidone and disappeared after stopping risperidone.